Moberg Pharma AB (publ) operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Moberg Pharma AB (publ) with three other
pharmaceutical manufacturers in Europe:
of the United Kingdom
sales of £171.67 million [US$214.32 million]
of which 100%
was Antibodies & Related Products),
(308,000.00 Swedish Kronor [US$35,016.52 ]
Hofseth Biocare ASA
based in Norway
(20.20 million Norwegian Kroner [US$2.39 million]
Moberg Pharma AB (publ) reported sales of SEK 334.30 million (US$38.01 million)
December of 2016.
increase of 17.1%
versus 2015, when the company's sales were SEK 285.57 million.
Sales at Moberg Pharma AB (publ) have increased during each of the previous five years
(and since 2011, sales have increased a total of 498%).